Both clinical investigations and animal studies identify A-FABP as a central mediator of obesity-related cardiovascular disease, possibly potentiating lipids-induced inflammation [1, 7]. The gene discussed is FABP4; the disease is obesity due to melanocortin 4 receptor deficiency.